Stacie C. Jeter

2.5k total citations
37 papers, 1000 citations indexed

About

Stacie C. Jeter is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Stacie C. Jeter has authored 37 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Stacie C. Jeter's work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (8 papers) and Estrogen and related hormone effects (6 papers). Stacie C. Jeter is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (8 papers) and Estrogen and related hormone effects (6 papers). Stacie C. Jeter collaborates with scholars based in United States, United Kingdom and India. Stacie C. Jeter's co-authors include Vered Stearns, Antonio C. Wolff, Zhe Zhang, Roisín M. Connolly, Karineh Tarpinian, Saraswati Sukumar, Deborah K. Armstrong, John H. Fetting, Anna Maria Storniolo and David A. Flockhart and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Stacie C. Jeter

37 papers receiving 990 citations

Peers

Stacie C. Jeter

ONCOL

PRM

PFM

William Irvin United States

Roberto Salgado Belgium

Antonella Savarese Italy

Ilaria Portarena Italy

Wayne Frederick United States

Ellen Copson United Kingdom

Tatjana Burchardt United States

Massimo Vaghi Italy

Emanuela Esposito Italy

Jawaid Younus Canada

William Irvin United States

Stacie C. Jeter

511 ×1.3

ONCOL

322 ×1.0

220 ×0.8

198 ×1.3

PRM

42 ×0.3

PFM

Citations per year, relative to Stacie C. Jeter Stacie C. Jeter (= 1×) peers William Irvin

Countries citing papers authored by Stacie C. Jeter

Since Specialization

Citations

This map shows the geographic impact of Stacie C. Jeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacie C. Jeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacie C. Jeter more than expected).

Fields of papers citing papers by Stacie C. Jeter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacie C. Jeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacie C. Jeter. The network helps show where Stacie C. Jeter may publish in the future.

Co-authorship network of co-authors of Stacie C. Jeter

This figure shows the co-authorship network connecting the top 25 collaborators of Stacie C. Jeter. A scholar is included among the top collaborators of Stacie C. Jeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacie C. Jeter. Stacie C. Jeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Litvak, Anya M., Stuart D. Russell, Hua‐Ling Tsai, et al.. (2018). Racial disparities in the rate of cardiotoxicity of HER2‐targeted therapies among women with early breast cancer. Cancer. 124(9). 1904–1911. 61 indexed citations

Santa‐Maria, Cesar A., Aditya Bardia, Amanda L. Blackford, et al.. (2018). A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. Breast Cancer Research and Treatment. 171(1). 121–129. 14 indexed citations

Stearns, Vered, Mary Jo Fackler, Zoila A. Lopez‐Bujanda, et al.. (2016). Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk. Cancer Prevention Research. 9(8). 673–682. 7 indexed citations

Blackford, Amanda L., Stacie C. Jeter, Jean L. Wright, et al.. (2016). Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins. Breast Cancer Research and Treatment. 160(2). 291–296. 13 indexed citations

Cimino‐Mathews, Ashley, Maria Cristina Figueroa Magalhães, Stacie C. Jeter, et al.. (2016). A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma. American Journal of Clinical Pathology. 145(3). 365–372. 71 indexed citations

Fackler, Mary Jo, Zoila A. Lopez‐Bujanda, Christopher B. Umbricht, et al.. (2014). Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer. Cancer Research. 74(8). 2160–2170. 118 indexed citations

Stearns, Vered, Lisa K. Jacobs, Theodore N. Tsangaris, et al.. (2013). Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer. Clinical Cancer Research. 19(14). 4008–4016. 24 indexed citations

Bao, Ting, Ling Cai, Jon T. Giles, et al.. (2013). A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors. Breast Cancer Research and Treatment. 138(1). 167–174. 66 indexed citations

Magarakis, Michael, Raghunandan Venkat, A. Lee Dellon, et al.. (2013). Pilot study of breast sensation after breast reconstruction: Evaluating the effects of radiation therapy and perforator flap neurotization on sensory recovery. Microsurgery. 33(6). 421–431. 51 indexed citations

10.

Rudek, Michelle A., Roisín M. Connolly, Janelle M. Hoskins, et al.. (2013). Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer. Breast Cancer Research and Treatment. 139(1). 135–143. 15 indexed citations

11.

Jelovac, Danijela, Julia A. Beaver, Balukrishna Sasidharan, et al.. (2013). A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers. Human Pathology. 45(4). 880–883. 11 indexed citations

12.

Jacobs, Michael A., Ronald Ouwerkerk, Antonio C. Wolff, et al.. (2011). Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer. Breast Cancer Research and Treatment. 128(1). 119–126. 63 indexed citations

13.

Bardia, Aditya, Zhe Zhang, Andrew P. DeFilippis, et al.. (2011). Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer. Breast Cancer Research and Treatment. 131(3). 907–914. 55 indexed citations

14.

Connolly, Roisín M., Michelle A. Rudek, Elizabeth Garrett‐Mayer, et al.. (2011). Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer. Breast Cancer Research and Treatment. 127(1). 153–162. 14 indexed citations

15.

Chumsri, Saranya, Stacie C. Jeter, Lisa K. Jacobs, et al.. (2010). Pathologic Complete Response to Preoperative Sequential Doxorubicin/Cyclophosphamide and Single-Agent Taxane With or Without Trastuzumab in Stage II/III HER2-Positive Breast Cancer. Clinical Breast Cancer. 10(1). 40–45. 14 indexed citations

16.

Kamdem, Landry K., Yong Liu, Vered Stearns, et al.. (2010). In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole. British Journal of Clinical Pharmacology. 70(6). 854–869. 60 indexed citations

17.

Rand, Kevin L., Julie L. Otte, David A. Flockhart, et al.. (2010). Modeling hot flushes and quality of life in breast cancer survivors. Climacteric. 14(1). 171–180. 45 indexed citations

18.

Otte, Julie L., David A. Flockhart, Daniel F. Hayes, et al.. (2009). Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy. Menopause The Journal of The North American Menopause Society. 16(4). 653–659. 20 indexed citations

19.

Bao, Ting, John H. Fetting, Laura M. Mumford, et al.. (2009). Severe prolonged cholestatic hepatitis caused by exemestane. Breast Cancer Research and Treatment. 121(3). 789–791. 5 indexed citations

20.

Carraway, Hetty E., Amanda L. Blackford, Penny Powers, et al.. (2008). Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence. Breast Cancer Research and Treatment. 114(2). 315–325. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact